- Previous Close
0.0500 - Open
0.0440 - Bid 0.0310 x --
- Ask 0.0500 x --
- Day's Range
0.0440 - 0.0500 - 52 Week Range
0.0300 - 0.0820 - Volume
3,700 - Avg. Volume
10,945 - Market Cap (intraday)
25.576M - Beta (5Y Monthly) 0.06
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 3, 2018
- 1y Target Est
--
Aoxin Q & M Dental Group Limited, an investment holding company, provides private dental healthcare services in the People's Republic of China. It operates through three segments: Primary Healthcare; Distribution of Dental Equipment and Supplies; and Laboratory Services. It offers private dental services, such as stomatology and general dentistry, endodontics, orthodontics, periodontics, prosthodontics, dental implantology, oral and maxillofacial surgery, aesthetic dentistry, and paedodontics; and operates dental centers comprising dental polyclinics and dental hospitals in Liaoning Province. The company also distributes and sells dental equipment and supplies, such as dental chairs, ultrasound scanners, dental instruments, and materials and consumables to dental hospitals, clinics, distributors, and laboratories. In addition, it provides laboratory services, which includes the manufacturing of porcelain crown, bridges, and dentures; and leases medical equipment. Further, the company offers technical and investment consultancy services; and develops dental inlay technology. Aoxin Q & M Dental Group Limited was founded in 1997 and is based in Singapore.
www.aoxinqm.com.sg--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1D4.SI
View MorePerformance Overview: 1D4.SI
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1D4.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1D4.SI
View MoreValuation Measures
Market Cap
25.58M
Enterprise Value
15.97M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.75
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.47
Enterprise Value/EBITDA
5.36
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.95%
Return on Assets (ttm)
3.05%
Return on Equity (ttm)
-0.66%
Revenue (ttm)
185.78M
Net Income Avi to Common (ttm)
-1.76M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
69.94M
Total Debt/Equity (mrq)
6.79%
Levered Free Cash Flow (ttm)
21.54M